Healthcare - Biotechnology - NASDAQ - US
$ 38.19
-4.26 %
$ 7.32 B
Market Cap
-19.89
P/E
Price Target
Average
119.75%
Revenue Forecast
Estimate
73.87%
EBIT
Estimate
--56.05%
Net Income
Estimate
28.39%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Legend Biotech Corporation
Wall Street analysts predict an average 1-year price target for LEGN of $83.9 , with forecasts ranging from a low of $60 to a high of $94 .
LEGN Lowest Price Target
Wall Street Target
60 USD
57.11%
LEGN Average Price Target
Wall Street Target
83.9 USD
119.75%
LEGN Highest Price Target
Wall Street Target
94 USD
146.14%
REVENUE FORECAST
Revenue Forecast Chart LEGN
EBIT FORECAST
EBIT Forecast Chart LEGN
NET INCOME FORECAST
Net Income Chart LEGN